Market Jar reports on market events, the hottest news in every market sector, and early investment opportunities for investors interested in small- and mid-cap opportunities.
No link added
Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s
Silo Pharma is trying to turn psychedelic-inspired science into everyday treatments for conditions like PTSD, chronic pain, Alzheimer’s, and multiple sclerosis—without the “trip,” using nasal sprays and tiny implants that aim to get medicine into the brain more effectively. The big question is whether upcoming early human studies and regulator sign-offs can validate the idea before the company needs more funding.Read more
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Security guards and cameras can’t cover every hospital, airport, or government site all day, and Knightscope is betting its patrol robots can fill those gaps. A recent push into government-ready deployments and new partners could open a much bigger customer base, but the company still has to prove it can scale beyond small pilots.Read more
The Next Phase of Energy Storage: How NeoVolta Is Tackling America’s Power Crunch
Power bills and grid strain are pushing more homes and small businesses to look for backup batteries, but many options still feel expensive or hard to install. NeoVolta positions itself as a faster-to-install alternative with a supply chain designed to avoid tariff shocks, while expanding from homes into bigger commercial sites.Read more